RIVERVIEW GROUP LLC 13D and 13G filings for POINT Biopharma Global Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:36 pm Purchase |
2021-12-31 | 13G | POINT Biopharma Global Inc. PNT |
RIVERVIEW GROUP LLC | 24,187 0.000% |
24,187 (New Position) |
Filing |